Omar Wever‐Pinzon

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy

Carolyn Y. Ho, Matthew E. Mealiffe, Richard G. Bach et al. · Journal of the American College of Cardiology · 2020 · 316 citations · Full text

Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II

Omar Wever‐Pinzon, Craig H. Selzman, Stavros G. Drakos et al. · Circulation Heart Failure · 2013 · 229 citations · Full text

Cardiac Recovery During Long-Term Left Ventricular Assist Device Support

Omar Wever‐Pinzon, Stavros G. Drakos, Stephen H. McKellar et al. · Journal of the American College of Cardiology · 2016 · 192 citations

Heart Failure, Assistive Technology, Device Therapy +5

Magnitude and Time Course of Changes Induced by Continuous-Flow Left Ventricular Assist Device Unloading in Chronic Heart Failure

Stavros G. Drakos, Omar Wever‐Pinzon, Craig H. Selzman et al. · Journal of the American College of Cardiology · 2013 · 185 citations · Full text

Changes Induced, Heart Failure, Chronic Heart Failure +11